AI-ECG Tracker vs KardiaAI
AI Verdict
Choose AI-ECG Tracker if…
Choose AI-ECG Tracker if your clinical setting requires a comprehensive, on-premise solution for 12-lead ECG auto-diagnosis with a dedicated workstation. This tool is ideal for hospitals or cardiology clinics needing rapid, highly accurate analysis across a wide range of cardiac classifications and detailed diagnostic capabilities for professional review and report generation.
View AI-ECG Tracker →Choose KardiaAI if…
Choose KardiaAI if you need to integrate medical-grade AI-powered ECG rhythm analysis into an existing mobile application, wearable device, or telehealth platform. This API library is best suited for scenarios involving ambulatory ECG monitoring, where the focus is on detecting common arrhythmias like AFib, bradycardia, and tachycardia from single-lead or short-duration recordings.
View KardiaAI →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | AI-ECG Tracker | KardiaAI |
|---|---|---|
| Pricing | Unknown | Subscription-based for advanced features and services. |
| Deployment | Mobile app, intended for use by qualified healthcare professionals in hospitals and other healthcare facilities. | Mobile app, cloud-based. |
| BAA Available | Unknown | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
KardiaAIKardiaAI, as an API library integrated into mobile apps and web platforms, offers greater flexibility and potential for seamless integration into existing, user-friendly interfaces. While AI-ECG Tracker provides a comprehensive workstation and client, KardiaAI's Software as a Medical Device (SaMD) approach allows for broader accessibility and adaptability across diverse clinical and patient-facing applications. AliveCor's own products (like KardiaMobile) are known for their user-friendliness, suggesting a strong focus on intuitive design for integrated solutions.
Clinical Value
AI-ECG TrackerAI-ECG Tracker offers a broader diagnostic scope, supporting 16 cardiac classifications and 104 ECG diagnostic classifications, including critical conditions like myocardial ischemia and infarction. It also provides a specific accuracy claim of over 95%. While KardiaAI is valuable for rhythm analysis, Tool A's comprehensive diagnostic capabilities suggest a higher overall clinical utility for full ECG interpretation in a professional setting.
Pricing & Value
KardiaAIKardiaAI provides transparent, publicly available subscription-based pricing, allowing potential users to clearly understand the cost and value proposition for different tiers. AI-ECG Tracker's pricing is not publicly available, making it impossible to assess its value without direct inquiry. This transparency gives KardiaAI an advantage in perceived value.
Enterprise Readiness
AI-ECG TrackerAI-ECG Tracker offers robust deployment options, including on-premise workstations and an optional cloud service, alongside a dedicated web-based management portal for organizational settings and task management. This comprehensive infrastructure is well-suited for traditional enterprise healthcare environments, providing greater control and integration capabilities within existing IT frameworks. Both tools claim HIPAA compliance and BAA (or likely BAA).
Innovation
KardiaAIKardiaAI's deployment as a Software as a Medical Device (SaMD) and an API library represents a highly innovative approach, enabling flexible integration into various mobile apps and web platforms. This architectural choice allows for broader application and scalability, aligning with modern digital health trends and fostering a more connected healthcare ecosystem. AI-ECG Tracker's innovation lies in its comprehensive diagnostic capabilities and speed within a more traditional system.
Support & Docs
KardiaAIAliveCor (KardiaAI) provides a more transparent and accessible support ecosystem, including public FAQs, user manuals for related devices, and developer documentation for its API. While Shenzhen Carewell Electronics Co. (AI-ECG Tracker) is a large company (Lepu Medical subsidiary), readily available public documentation or a dedicated support portal for the AI-ECG Tracker product is less evident from web searches.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | AI-ECG Tracker | KardiaAI |
|---|---|---|
| Company | Shenzhen Carewell Electronics Co. | AliveCor |
| Tagline | Forever Innovation Forever Care! | Transforming cardiology with its medical-grade AI solutions. |
| Key Features (ECG Analysis) | AI-powered ECG auto-analysis and diagnosis, high accuracy (over 95%) for common cardiac abnormalities including arrhythmias, ventricular hypertrophy, myocardial ischemia, and myocardial infarction, comprehensive diagnosis support for 16 cardiac classifications and 104 ECG diagnostic classifications. | AI-powered ECG analysis library, detection of atrial fibrillation, bradycardia, tachycardia, and normal sinus rhythm, detection of Sinus Rhythm with Premature Ventricular Contractions (PVCs), detection of Sinus Rhythm with Wide QRS, detection of Sinus Rhythm with Supraventricular Ectopy (SVE), ECG noise filtering and noisy ECG detection. |
Videos
Demos, reviews, and walkthroughs featuring AI-ECG Tracker and KardiaAI.
Frequently Asked Questions
More Comparisons
More matchups featuring AI-ECG Tracker or KardiaAI
Backers
Who funded each tool's parent company.